Clinical Trials Directory

Trials / Completed

CompletedNCT01793961

Effects of Chronic Intake of Cannabis on Contrast Sensitivity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
95 (actual)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Rates of driving under the influence of cannabis have risen in recent years. Cannabis is involved in 1/3 of motor vehicle collisions. The chronic use of cannabis is known to affect dopaminergic regulation and may thus impair contrast sensitivity. In turn, contrast sensitivity disorders could originate difficulties to anticipate and avoid collision with objects, especially when objects are in movement. The investigators goal is to examine the effects of a chronic intake of cannabis on contrast sensitivity. The observed values will be compared to standard references. In addition, since smoking cannabis is always associated with tobacco, the investigators will control the effects of tobacco on contrast sensitivity. In this study, the investigators will include 36 cannabis addicts, 36 tobacco addicts and 36 no smokers. The investigators will present gratings with different spatial frequencies and the investigators will determine contrast thresholds for static and dynamic (moving) gratings. The investigators predict that cannabis addicts will present abnormal contrast sensitivity especially in case of dynamic presentation of gradings.

Conditions

Interventions

TypeNameDescription
OTHERelectroretinogram
OTHERcontrast sensitivity tests

Timeline

Start date
2013-03-22
Primary completion
2015-11-30
Completion
2018-09-10
First posted
2013-02-18
Last updated
2019-07-12

Source: ClinicalTrials.gov record NCT01793961. Inclusion in this directory is not an endorsement.